<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BMRN
BioMarin
$
()


  • BioMarin initiated with a Market Perform at Raymond James

    Today - 06:27am
  • BioMarin receives FDA orphan designation for HCM treatment

    9/26/2023 - 17:58pm
  • BioMarin to present data showing LT benefit of Voxzogo on children's growth

    9/21/2023 - 10:02am
  • Micron upgraded, PayPal downgraded: Wall Street's top analyst calls

    9/18/2023 - 09:55am
  • BioMarin initiated with a Buy at UBS

    9/18/2023 - 05:39am
  • BioMarin receives positive CHMP opinion in Europe to expand use of VOXZOGO

    9/15/2023 - 09:30am
  • BioMarin to hold virtual meeting

    9/12/2023 - 07:55am
  • BioMarin to hold virtual meeting

    9/12/2023 - 04:55am
  • BioMarin to hold virtual meeting

    9/11/2023 - 22:02pm
  • BioMarin says first person treated commercially with ROCTAVIAN

    8/30/2023 - 16:10pm
  • BioMarin participates in a conference call with Jefferies

    8/23/2023 - 12:55pm
  • BioMarin participates in a conference call with Jefferies

    8/23/2023 - 11:17am
  • BioMarin treatment of hypochondroplasia granted FDA orphan status

    8/1/2023 - 14:56pm
  • BioMarin price target lowered to $108 from $118 at Stifel

    8/1/2023 - 08:01am
  • BioMarin raises FY23 non-GAAP EPS view to $1.85-$2.10 from $1.80-$2.05

    7/31/2023 - 16:07pm
dynamic_feed Breaking News